VDC launches pounds 30m Lawrence bid
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AIM-LISTED VDC, a distributor of drugs and surgery instruments to veterinarians, has launched a pounds 30m bid for rival Lawrence in an attempt to head off a pounds 20.7m hostile bid from cattle-breeding company Genus.
VDC, which already controls 76.2 per cent of Lawrence, has offered 66 of its own shares for every 30 Lawrence shares, valuing each Lawrence share at 435.6p - a 22 per cent premium on Friday's closing market price. The two companies said they plan to form the largest Alternative Investment Market-listed animal health and additives company.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments